» Articles » PMID: 27334497

Preliminary Study on Serum Paraoxonase-1 Status and Chemokine (C-C Motif) Ligand 2 in Hospitalized Elderly Patients with Catheter-associated Asymptomatic Bacteriuria

Overview
Publisher Springer
Date 2016 Jun 24
PMID 27334497
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Urinary tract infections (UTI) are common among elderly patients in residential care facilities, as well as in the hospital setting. Identifying new biochemical markers of UTI is an active line of research since UTI management is resource intensive. Paraoxonase-1 (PON1) forms part of the patient's immune system, the response-to-injury and inflammation. Our study sought to evaluate alterations in inflammation-related paraoxonase-1 (PON1) and chemokine (C-C motif) ligand 2 (CCL2) in patients with an indwelling catheter to assess their potential usefulness as biomarkers of infection. Patients (n = 142) who had had the urinary catheter removed and 100 healthy volunteers were recruited. In all participants we measured serum PON1 activity, PON1 concentration, CCL2, procalcitonin and C-reactive protein (CRP). Results indicated that patients had higher CCL2, CRP and procalcitonin concentrations than the control group, and lower paraoxonase activity. There were no significant differences in PON1 concentrations. When comparing the diagnostic accuracy of CRP, procalcitonin, CCL2 and the PON1-related variables in discriminating between patients with and those without UTI, we found a considerable degree of overlap between groups, i.e., a low diagnostic accuracy. However, there were significant inverse logarithmic correlations between serum paraoxonase activity and the number of days the urinary catheter had been in situ. Our results suggest that measurement of these biochemical variables may be useful in investigating complications of long-term use of these devices and help to improve the economic and clinical investment required in the management of the often-associated infection.

Citing Articles

Differential analysis of lipoprotein and glycoprotein profiles in bacterial infections and COVID-19 using proton nuclear magnetic resonance and machine learning.

Iftimie S, Amigo N, Martinez-Micaelo N, Lopez-Azcona A, Martinez-Navidad C, Castane H Heliyon. 2024; 10(17):e37115.

PMID: 39286163 PMC: 11402779. DOI: 10.1016/j.heliyon.2024.e37115.


Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study.

El-Derany M, Hanna D, Youshia J, Elmowafy E, Farag M, Azab S Pharmacol Rep. 2023; 75(5):1045-1065.

PMID: 37587394 PMC: 10539420. DOI: 10.1007/s43440-023-00517-w.


Combining Semi-Targeted Metabolomics and Machine Learning to Identify Metabolic Alterations in the Serum and Urine of Hospitalized Patients with COVID-19.

Baiges-Gaya G, Iftimie S, Castane H, Rodriguez-Tomas E, Jimenez-Franco A, Lopez-Azcona A Biomolecules. 2023; 13(1).

PMID: 36671548 PMC: 9856035. DOI: 10.3390/biom13010163.


Measurement of Plasma Galectin-3 Concentrations in Patients with Catheter Infections: A Post Hoc Retrospective Cohort Study.

Iftimie S, Hernandez-Aguilera A, Lopez-Azcona A, Castane H, Rodriguez-Tomas E, Baiges-Gaya G Diagnostics (Basel). 2022; 12(10).

PMID: 36292107 PMC: 9599992. DOI: 10.3390/diagnostics12102418.


Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19.

Gabaldo X, Juanpere M, Castane H, Rodriguez-Tomas E, Lopez-Azcona A, Baiges-Gaya G Biomolecules. 2022; 12(7).

PMID: 35883435 PMC: 9312761. DOI: 10.3390/biom12070879.


References
1.
Henriquez-Camacho C, Losa J . Biomarkers for sepsis. Biomed Res Int. 2014; 2014:547818. PMC: 3985161. DOI: 10.1155/2014/547818. View

2.
Sans T, Rull A, Luna J, Mackness B, Mackness M, Joven J . Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report. Clin Chem Lab Med. 2012; 50(8):1409-15. DOI: 10.1515/cclm-2011-0896. View

3.
Ramanathan R, Duane T . Urinary tract infections in surgical patients. Surg Clin North Am. 2014; 94(6):1351-68. DOI: 10.1016/j.suc.2014.08.007. View

4.
Petrkova J, Szotkowska J, Hermanova Z, Lukl J, Petrek M . Monocyte chemoattractant protein-1 in patients with peripheral arterial disease. Mediators Inflamm. 2004; 13(1):39-43. PMC: 1781535. DOI: 10.1080/09629350410001664752. View

5.
Iftimie S, Garcia-Heredia A, Pujol I, Ballester F, Fort-Gallifa I, Simo J . A preliminary study of paraoxonase-1 in infected patients with an indwelling central venous catheter. Clin Biochem. 2015; 49(6):449-457. DOI: 10.1016/j.clinbiochem.2015.11.006. View